The story of Cordio Medical was recently covered by Alex Knapp, for Forbes magazine.

Cordio’s app, HearO, uses state-of-the-art voice recognition, voice analysis software, and machine learning, to detect changes in a patient’s voice. These changes indicate fluid accumulation in the lungs, one of the main problems with patients suffering from congestive heart failure (CHF).

​

This early identification allows doctors to intervene with medicine and prevent a patient’s condition from deteriorating to a point where hospitalization is needed.

​

“What’s exciting about this one is its simplicity, its elegance, and that it’s ready to be universally deployed to our heart failure patients,” says William Abraham, a cardiologist at Ohio State University’s Wexner Medical Center.

​

Over 5 million Americans are diagnosed with CHF.